Consistently, our previous work showed loss of Zhx2 enhanced lipid accumulation to promote NAFLD progression and increased mitochondria-mediated lipid oxidation to provide ATP for rapid hepatocytes proliferation during NAFLD-HCC transition27. This evidence concerns the gene ZHX2 and metabolic dysfunction-associated steatotic liver disease.